AINewsWire Editorial Coverage: A tectonic shift is reshaping global semiconductor manufacturing. Hundreds of billions of dollars i ...
In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...
June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's (SASY.PA), opens new tab type 1 diabetes injection in children aged 8 to ‌17 years ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A Chinese-speaking cybercrime group has expanded its targeting to the European space, deploying previously undocumented malware and the Atlas backdoor. Tracked as TA4922, the threat actor is ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ImmunityBio receives good news all around – the U.S. Food and Drug Administration has accepted for review the company’s application for expanded use of Anktiva and it acquired a strain of a related ...
Anthropic is expanding Project Glasswing, its joint industry initiative to find and fix critical software vulnerabilities using AI, to about 150 new organizations across more than 15 countries, the ...
June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's type 1 diabetes injection in children aged 8 to 17 years who were recently ...
Sanofi SNY announced that the FDA has approved its type I diabetes (T1D) drug, Tzield (teplizumab), for a new indication under the accelerated pathway. The agency has cleared the therapy to delay the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results